Affinity Asset Advisors

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Verona Pharma plc
VRNA
$13.16M8.07817,833+45.05%+$4.09M0.2
Perspective Therapeutics, Inc.
CATX
$6.07B7.575.1MNew+$6.07B91.51
NextCure, Inc.
NXTC
$3.03M4.861.36MNew+$3.03M0.05
Inozyme Pharma, Inc.
INZY
$20.24M4.272.64M+40.13%+$5.8M0.31
Rezolute, Inc.
RZLT
$4.08M3.111.6MNew+$4.08M0.06
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.